Table A.1.
Description of the Quality and Outcomes Framework disease areas and treatments recorded in the Health Survey for England.
| Indicator | Description |
|---|---|
| ASTHMA 5 | The percentage of patients with asthma who smoke, and whose notes contain a record that smoking cessation advice has been offered within last 15 months |
| ASTHMA 6 | The percentage of patients with asthma who have had an asthma review in the last 15 months |
| BP3 | The percentage of patients with hypertension who smoke, whose notes contain a record that smoking cessation advice has been offered at least once |
| BP4 | The percentage of patients with hypertension in which there is a record of the blood pressure in the past 9 months |
| CHD4 | The percentage of patients with coronary heart disease who smoke, whose notes contain a record that smoking cessation advice has been offered within the last 15 months |
| CHD7 | The percentage of patients with coronary heart disease whose notes have a record of total cholesterol in the previous 15 months |
| CHD9 | The percentage of patients with coronary heart disease with a record in the last 15 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken (unless a contraindication or side effects are recorded) |
| CHD10 | The percentage of patients with coronary heart disease who are currently treated with a beta blocker (unless a contraindication or side-effects are recorded) |
| CHD11 | The percentage of patients with a history of myocardial infarction (diagnosed after 1 April 2003) who are currently treated with an ACE inhibitor |
| DM2 | The percentage of patients with diabetes whose notes record BMI in the previous 15 months |
| DM4 | The percentage of patients with diabetes who smoke and whose notes contain a record that smoking cessation advice has been offered in the last 15 months |
| DM5 | The percentage of diabetic patients who have a record of HbA1c or equivalent in the previous 15 months |
| DM15 | The percentage of patients with diabetes with proteinuria or micro-albuminuria who are treated with ACE inhibitors (or A2 antagonists) |
| MH2 | The percentage of patients with severe long-term mental health problems with a review recorded in the preceding 15 months. This review includes a check on the accuracy of prescribed medication, a review of physical health and a review of co-ordination arrangements with secondary care |
| STROKE2 | The percentage of new patients with presumptive stroke (presenting after 01/04/03) who have been referred for confirmation of the diagnosis by CT or MRI scan |
| STROKE4 | The percentage of patients with a history of TIA or stroke who smoke and whose notes contain a record that smoking cessation advice has been offered in the last 15 months |
| STROKE9 | The percentage of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded) |